Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

CANNABIS STRATEGIC VENTURES logo
NUGS

CANNABIS STRATEGIC VENTURES

MaveScore 46 Low model confidence
Last Price US$0.00 As of Jun 15, 2026
Market Cap US$207100.0 Company size context
7D Performance 0.00% Past 7 days
1Y Performance 1200.00% Past 12 months
Model Rating
Historical model output for research review

Fundamental data date

Dec 31, 2014

4185 days old

Market price date

Jun 15, 2026

1 day old

Coverage

13/16

3 missing model inputs

Data quality

Review

Partial or delayed snapshot

Transparent research score

Why the model scores this stock

MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

MaveScore 46 Low confidence

Stored data quality

Freshness and coverage checks

Stored company inputs are available, but some dates or model fields are older or incomplete.

13/16 Partial or delayed snapshot

Quality

Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.

12/35 Weak

Financial Strength

Financial strength rewards durable profitability, margins, and positive free cash flow.

20/25 Strong

Valuation Support

Valuation needs price plus per-share earnings, cash-flow, or book-value inputs.

0/15 Needs Data

Momentum

Momentum highlights research candidates with supportive 3-month and 6-month price regimes.

14/15 Strong

Shareholder Alignment

Shareholder alignment rewards less dilutive share behavior and enough size for liquid research coverage.

0/10 Weak

Positive model output

  • Financial strength rewards durable profitability, margins, and positive free cash flow.
  • Momentum highlights research candidates with supportive 3-month and 6-month price regimes.

Research risks to review

  • Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.
  • Valuation needs price plus per-share earnings, cash-flow, or book-value inputs.
  • Shareholder alignment rewards less dilutive share behavior and enough size for liquid research coverage.

MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting. Missing inputs right now include free cash flow per share, book value per share, earnings per share.

Dashboard Funda..tals Deep..lue Prediction Screener Map

CANNABIS STRATEGIC VENTURES Overview

Industry: Drug Manufacturers Specialty & Generic

Sector: Healthcare

Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.

CANNABIS STRATEGIC VENTURES is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review CANNABIS STRATEGIC VENTURES in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



CANNABIS STRATEGIC VENTURES Competitors

CANNABIS STRATEGIC VENTURES operates in the Drug Manufacturers Specialty & Generic industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

CANNABIS STRATEGIC VENTURES

US$0.00

US$207100.0

0.00%

1200.00%